Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Acute Toxicity: inhalation

Currently viewing:

Administrative data

Endpoint:
acute toxicity: inhalation
Type of information:
experimental study
Adequacy of study:
key study
Study period:
1991/07/19 - 1991/10/16
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
guideline study

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
1991
Report date:
1991

Materials and methods

Test guideline
Qualifier:
according to guideline
Guideline:
OECD Guideline 403 (Acute Inhalation Toxicity)
GLP compliance:
yes
Test type:
traditional method
Limit test:
no

Test material

Constituent 1
Chemical structure
Reference substance name:
Tetraethyl orthosilicate
EC Number:
201-083-8
EC Name:
Tetraethyl orthosilicate
Cas Number:
78-10-4
Molecular formula:
C8H20O4Si
IUPAC Name:
tetraethyl orthosilicate
Test material form:
liquid

Test animals

Species:
rat
Strain:
other: Wiskf(SPF71)
Sex:
male/female
Details on test animals or test system and environmental conditions:
TEST ANIMALS
- Source: HOECHST AG, Kastengrund, SPF-Zucht

- Age at study initiation: 8-10 weeks

- Weight at study initiation: Male rats weighed 193-234 g at the time of dosing and female rats weighed 190-202 g at dosing 

- Housing: In an airconditioned room in Makrolon type 4 cages, 5 animals per cage

- Diet: Rat diet Altromin 1324, ad libitum

- Water: Tap water, ad libitum

- Acclimation: At least 5 days

ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22 +/- 2

- Humidity (%): 50 +/- 20

- Photoperiod (hrs dark / hrs light): 12/12

Administration / exposure

Route of administration:
inhalation: aerosol
Type of inhalation exposure:
nose/head only
Vehicle:
other: unchanged (no vehicle)
Details on inhalation exposure:
GENERATION OF TEST ATMOSPHERE / CHAMBER DESCRIPTION
- Exposure apparatus: The test substance was injected into the chamber at constant velocity through an infusion apparatus at one end of the chamber.

- Exposure chamber volume: 60 L

- Method of holding animals in test chamber: The animals were in a stainless steel and glass cylinder, with plastic tubes leading to the exposure cylinder designed so that the animal's noses fit inside.

- Source and rate of air: The air supply was kept constant at 800 L/h through a calibrated rotameter.

- Method of conditioning air: A suction device at the bottom of the inhalation chamber enabled the air to be passed through, attached to a water bottle, a Buehler filter and a bottle of calcium chloride.

- System of generating particulates/aerosols: The primary aerosol formation took place in the generation flasks, and the smaller particles were passed into the inhalation chamber through a riser pipe.

- Method of particle size determination: Determination of the particle size was only possible at the highest concentration because the test substance was mostly in the gaseous phase as the concentrations decreased.

- Treatment of exhaust air: Exhaust air was extracted and neutralised.

- Temperature, humidity, pressure in air chamber: An air monitoring system (Hartmann & Braun) continuously recorded CO, CO2, O2, humidity and temperature in the exposure chamber.

TEST ATMOSPHERE
- Brief description of analytical method used: For the determination of the test material concentration in the inhalation chamber, 31 L of the test atmosphere during a 60-minute period of the exposure period was analysed by passing it through a series of connected gas wash bottles which were completely filled with 70, 60 and 50 mL absolute ethanol residing in a cold bath. The distribution of aerosol particle size was determined using an Anderson-Cascade Impactor 3 (Anderson Samples Inc, Atlanta). Mean relative abundances of aerodynamic diameter were determined. The device was operated at a vacuum flow rate of 9.5 L/min, from which a flow velocity of 1.25 m/s was calculated.

- Samples taken from breathing zone: Yes

TEST ATMOSPHERE (if not tabulated)
- MMAD (Mass median aerodynamic diameter) / GSD (Geometric st. dev.): 0.8 micrometers / 1.7.
Analytical verification of test atmosphere concentrations:
yes
Remarks:
Gas chromatography using an FID as a detector.
Duration of exposure:
4 h
Concentrations:
5.74, 9.98, 10.40 and 16.83 mg/L
No. of animals per sex per dose:
5M, 5F per dose, except no females in the 5.74 mg/L dose
Control animals:
no
Details on study design:
- Duration of observation period following administration: 14 days

- Frequency of observations and weighing: Rats were observed for clinical symptoms during the 4-hour exposure period and then twice per day for 14 days post exposure. Body weights were determined prior to dosing and on days 8 and 15 of the study.

- Necropsy of survivors performed: Yes
Statistics:
The LC50 and 95% confidence limits were calculated according to Fieller and Sidak and probit analysis was carried out on the mortality data according to Finney and Weber.

Results and discussion

Effect levelsopen allclose all
Sex:
male
Dose descriptor:
LC50
Effect level:
10 mg/L air
Exp. duration:
4 h
Remarks on result:
other: aerosol
Sex:
female
Dose descriptor:
LC50
Effect level:
> 16.8 mg/L air
Exp. duration:
4 h
Remarks on result:
other: aerosol
Mortality:
Deaths first occurred on or just before the 3rd test day. Please see Table 1.
Clinical signs:
other: The animals showed reactions involving motor behavior and respiration, palpebral stenosis extending to full lid closure with encrusted blood covered eyelid rims, shivering and tonic cramping. Cyanosis and decreased reflexes occurred in individual animals.
Body weight:
Body weights were decreased during the study but by the completion of the study, all the animals exceeded their initial weight.
Gross pathology:
Necropsy results from animals which died during the study showed red and orange coloured lungs, release of froth upon incision of the lungs and lung spotting. Spotting or light colouration of the lungs were found in every female rat sacrificed at the end of the study. There were no macroscopic findings in the male rats sacrificed at the end of the study.

Any other information on results incl. tables

Table 1: Concentrations, exposure conditions and mortality per animals treated

 

Analytical Conc. (mg/L)

Mortality (# dead/total)

Males

Females

Combined

 5.74

 1/5

 -

1/5 

 9.98

 2/5

 0/5

 2/10

 10.40

3/5

1/5

4/10

 16.83

4/5 

 1/5

 5/10

- = Not tested

Value [LC50]: 10.0 mg/L for male rats and >16.8 mg/L for female rats. 

Applicant's summary and conclusion

Interpretation of results:
GHS criteria not met
Conclusions:
In a study conducted according to OECD Test Guideline 403 and GLP compliant (reliability score 1), tetraethyl orthosilicate was determined to have a 4-hour LC50 of 10.0 mg/L aerosol in male rats and >16.8 mg/l aerosol in female rats.